Summary & Overview
CPT 89320: Comprehensive Semen Analysis for Male Fertility Assessment
CPT code 89320 represents a comprehensive laboratory semen analysis, a critical diagnostic procedure in reproductive medicine for evaluating male fertility. This code encompasses assessment of semen volume, sperm count, motility, and differential analysis, providing essential information for clinicians managing infertility and related conditions. The procedure is most commonly performed in independent laboratory settings and is recognized by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare.
This publication offers a detailed overview of the clinical context and billing considerations for CPT code 89320. Readers will gain insight into payer coverage, typical sites of service, and the role of this code in reproductive health diagnostics. The report also highlights relevant modifiers, associated provider taxonomies, and common ICD-10 diagnoses linked to male infertility and fertility testing. Additionally, related CPT codes are discussed to clarify distinctions in laboratory testing for semen analysis.
Healthcare professionals, laboratory directors, and policy analysts will find this summary useful for understanding national benchmarks, policy updates, and the evolving landscape of reproductive laboratory procedures. The information provided supports accurate coding, billing, and clinical documentation for comprehensive semen analysis services.
CPT Code Overview
CPT code 89320 is used to report a comprehensive semen analysis performed by a laboratory analyst. This procedure includes evaluation of semen volume, sperm count, motility, and differential analysis of the ejaculate from a male patient. It is a key diagnostic tool in reproductive medicine, particularly for assessing male fertility. The service is classified under Pathology and Laboratory Procedures — Reproductive Medicine Procedures and is typically performed in an Independent Laboratory setting (Place of Service 81).
Clinical & Coding Specifications
Clinical Context
A male patient presents to an independent laboratory for evaluation of fertility concerns. The clinician orders a semen analysis to assess reproductive health. The laboratory analyst collects the ejaculate specimen and performs a comprehensive analysis, including measurement of semen volume, sperm count, motility, and differential assessment. The results assist the referring provider in diagnosing conditions such as male infertility, azoospermia, or oligospermia, and guide further management or fertility treatment options.
Coding Specifications
-
Modifiers:
- Modifier
26: Used when reporting only the professional component of the service (interpretation of results). - Modifier
TC: Used when reporting only the technical component (performance of the laboratory test).
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
207ZP0102X | Pathology |
207V00000X | Obstetrics & Gynecology |
207Q00000X | Family Medicine |
207PE0004X | Reproductive Endocrinology |
207U00000X | Clinical Laboratory Director, Non-physician |
These taxonomies represent specialties commonly involved in ordering, performing, or interpreting semen analysis procedures.
Related Diagnoses
-
N46.9— Male infertility, unspecified- Used when the patient is evaluated for infertility without a specific cause identified.
-
Z31.41— Encounter for fertility testing- Applied when the visit is specifically for fertility assessment, such as semen analysis.
-
N46.01— Azoospermia- Indicates absence of sperm in the ejaculate, a key finding from semen analysis.
-
N46.11— Oligospermia- Denotes low sperm count, which is determined through semen analysis.
-
N46.8— Other male infertility- Used for infertility diagnoses not otherwise specified, often based on semen analysis findings.
Related CPT Codes
-
89310: The lab analyst performs a semen analysis, including motility and count, but not including the post coital Huhner test, on the ejaculate from a male patient.- This code is related to
89320but does not include the full differential analysis. It may be used for less comprehensive semen evaluations.
- This code is related to
-
89321: The lab analyst performs the technical lab test to analyze a semen specimen for the presence of sperm. The code also includes checking for sperm motility if the analyst performs that service, too.- This code focuses on the technical assessment for sperm presence and motility, and may be used as an alternative or in conjunction with
89320depending on clinical needs.
- This code focuses on the technical assessment for sperm presence and motility, and may be used as an alternative or in conjunction with
These codes are commonly used as alternatives or adjuncts to 89320 in reproductive medicine workflows.
National Reimbursement Benchmarks
For CPT code 89320, the national mean rate for BUCA (average commercial) payers is $13.10, which is higher than the typical Medicare rate for similar codes, though Medicare data is not available in the input for direct comparison. Among individual commercial payers, Cigna has the highest mean rate at $15.84, while Blue Cross Blue Shield and UnitedHealth Group are lower at $12.17 and $12.68, respectively.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Cigna shows the widest spread at $10.25, indicating greater variability in contracted rates. Blue Cross Blue Shield has a tighter range of $5.17, suggesting more consistent rates nationally. The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.